Shifa International Hospitals Limited (PSX:SHFA)
Pakistan · Delayed Price · Currency is PKR 547.12
+15.42 (2.90%)
At close: Sep 26, 2025
PSX:SHFA Revenue
In the fiscal year ending June 30, 2025, Shifa International Hospitals had annual revenue of 27.97B PKR with 18.74% growth. Shifa International Hospitals had revenue of 7.10B in the quarter ending June 30, 2025, with 23.17% growth.
Revenue
27.97B
Revenue Growth
+18.74%
P/S Ratio
1.24
Revenue / Employee
5.23M
Employees
5,348
Market Cap
34.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 27.97B | 4.41B | 18.74% |
| Jun 30, 2024 | 23.55B | 3.85B | 19.57% |
| Jun 30, 2023 | 19.70B | 3.51B | 21.66% |
| Jun 30, 2022 | 16.19B | 1.97B | 13.84% |
| Jun 30, 2021 | 14.22B | 1.96B | 16.02% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GlaxoSmithKline Pakistan | 62.62B |
| Abbott Laboratories (Pakistan) | 72.39B |
| Highnoon Laboratories | 25.78B |
| The Searle Company | 29.12B |
| AGP Limited | 26.11B |
| Citi Pharma | 12.97B |
| Macter International | 8.48B |
| Ferozsons Laboratories | 18.86B |